Cargando…

Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus

BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Schliefsteiner, Carolin, Peinhaupt, Miriam, Kopp, Susanne, Lögl, Jelena, Lang-Olip, Ingrid, Hiden, Ursula, Heinemann, Akos, Desoye, Gernot, Wadsack, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534476/
https://www.ncbi.nlm.nih.gov/pubmed/28824621
http://dx.doi.org/10.3389/fimmu.2017.00888
_version_ 1783253771683364864
author Schliefsteiner, Carolin
Peinhaupt, Miriam
Kopp, Susanne
Lögl, Jelena
Lang-Olip, Ingrid
Hiden, Ursula
Heinemann, Akos
Desoye, Gernot
Wadsack, Christian
author_facet Schliefsteiner, Carolin
Peinhaupt, Miriam
Kopp, Susanne
Lögl, Jelena
Lang-Olip, Ingrid
Hiden, Ursula
Heinemann, Akos
Desoye, Gernot
Wadsack, Christian
author_sort Schliefsteiner, Carolin
collection PubMed
description BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-inflammatory phenotype in HBCs. The pilot-study presented here challenges this claim, showing that HBCs maintain anti-inflammatory properties in spite of the hyperglycemic, low-grade inflammatory environment of GDM. METHODS: HBCs were isolated from placentae of healthy women (N = 5) and women with GDM (N = 6) diagnosed in the second trimester. FACS was used to measure surface markers associated with either M1 or M2 phenotype on the cells. In addition, placental tissue sections were subjected to immune histochemical imaging to assess the phenotype within the tissue context. Supernatant from control and GDM HBCs was collected at defined time points and used in a multiplex ELISA-on-beads approach to assess secretion of cytokines, chemokines, and growth factors. The effect of HBC cell culture supernatant on placental endothelial activation was investigated. RESULTS: FACS and immune staining showed that, indeed, M2 markers, such as CD206 and CD209, are increased in HBCs isolated from GDM placentae. Also, the M1 marker CD86 was increased, but only by trend. Secretion of numerous cytokines, chemokines and growth factors was not changed; pro-inflammatory interleukin (IL)-1β and IL-6 release form GDM HBC was increased but not significant. Exposure to GDM HBC supernatant did not induce cell adhesion molecules (VCAM-1, selectins, vascular endothelial-cadherin) in placental endothelial cells compared to supernatant from control HBCs, an induction of intracellular adhesion molecule 1 was observed however. CONCLUSION: Our study—although performed in a small set of patients—shows that placental macrophages maintain their anti-inflammatory, tissue remodeling M2 phenotype even in pregnancies affected by gestational diabetes. This consistent phenotype might be important for propagation of maternal tolerance toward the fetus and for protection of the fetus from a low-grade inflammatory environment.
format Online
Article
Text
id pubmed-5534476
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55344762017-08-18 Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus Schliefsteiner, Carolin Peinhaupt, Miriam Kopp, Susanne Lögl, Jelena Lang-Olip, Ingrid Hiden, Ursula Heinemann, Akos Desoye, Gernot Wadsack, Christian Front Immunol Immunology BACKGROUND: Hofbauer cells (HBCs) are macrophages of the feto-placental unit. Despite the general view that these cells have an anti-inflammatory M2 phenotype, recent studies have claimed that pregnancy pathologies—e.g., gestational diabetes mellitus (GDM)—cause a switch from an M2 to an M1 pro-inflammatory phenotype in HBCs. The pilot-study presented here challenges this claim, showing that HBCs maintain anti-inflammatory properties in spite of the hyperglycemic, low-grade inflammatory environment of GDM. METHODS: HBCs were isolated from placentae of healthy women (N = 5) and women with GDM (N = 6) diagnosed in the second trimester. FACS was used to measure surface markers associated with either M1 or M2 phenotype on the cells. In addition, placental tissue sections were subjected to immune histochemical imaging to assess the phenotype within the tissue context. Supernatant from control and GDM HBCs was collected at defined time points and used in a multiplex ELISA-on-beads approach to assess secretion of cytokines, chemokines, and growth factors. The effect of HBC cell culture supernatant on placental endothelial activation was investigated. RESULTS: FACS and immune staining showed that, indeed, M2 markers, such as CD206 and CD209, are increased in HBCs isolated from GDM placentae. Also, the M1 marker CD86 was increased, but only by trend. Secretion of numerous cytokines, chemokines and growth factors was not changed; pro-inflammatory interleukin (IL)-1β and IL-6 release form GDM HBC was increased but not significant. Exposure to GDM HBC supernatant did not induce cell adhesion molecules (VCAM-1, selectins, vascular endothelial-cadherin) in placental endothelial cells compared to supernatant from control HBCs, an induction of intracellular adhesion molecule 1 was observed however. CONCLUSION: Our study—although performed in a small set of patients—shows that placental macrophages maintain their anti-inflammatory, tissue remodeling M2 phenotype even in pregnancies affected by gestational diabetes. This consistent phenotype might be important for propagation of maternal tolerance toward the fetus and for protection of the fetus from a low-grade inflammatory environment. Frontiers Media S.A. 2017-07-31 /pmc/articles/PMC5534476/ /pubmed/28824621 http://dx.doi.org/10.3389/fimmu.2017.00888 Text en Copyright © 2017 Schliefsteiner, Peinhaupt, Kopp, Lögl, Lang-Olip, Hiden, Heinemann, Desoye and Wadsack. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Schliefsteiner, Carolin
Peinhaupt, Miriam
Kopp, Susanne
Lögl, Jelena
Lang-Olip, Ingrid
Hiden, Ursula
Heinemann, Akos
Desoye, Gernot
Wadsack, Christian
Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title_full Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title_fullStr Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title_full_unstemmed Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title_short Human Placental Hofbauer Cells Maintain an Anti-inflammatory M2 Phenotype despite the Presence of Gestational Diabetes Mellitus
title_sort human placental hofbauer cells maintain an anti-inflammatory m2 phenotype despite the presence of gestational diabetes mellitus
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534476/
https://www.ncbi.nlm.nih.gov/pubmed/28824621
http://dx.doi.org/10.3389/fimmu.2017.00888
work_keys_str_mv AT schliefsteinercarolin humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT peinhauptmiriam humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT koppsusanne humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT logljelena humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT langolipingrid humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT hidenursula humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT heinemannakos humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT desoyegernot humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus
AT wadsackchristian humanplacentalhofbauercellsmaintainanantiinflammatorym2phenotypedespitethepresenceofgestationaldiabetesmellitus